TrialEuropean heart journal2020

Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial.

David Fitchett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.